Patents by Inventor Alan Davison

Alan Davison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11953111
    Abstract: A split body, rotary C gate, removeable stem vacuum valve using an input assembly with handle extensions that allow for hand movement of the incoming pipe to access an inner aperture body with a curved sealing face that directly seals to a C shaped gasketless gate that can be rotated into and out of the inner body aperture for easy cleaning. The gasketless gate is held in position using gate axles with an outer axle stem connected to a polygon lower body that mates into a matching polygon aperture on the gasketless gate. The middle valve assembly's gasketless housing body defines upper and lower axle washer pockets for locating the axles for proper operation and simple axle pins for securing the axles in position.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: April 9, 2024
    Inventors: Clay Owens, Alan Davison, Chris Clouse, Jerry George McGarrah
  • Publication number: 20230238091
    Abstract: Systems for use with a medical device for controlling an infusion device are provided. In one aspect, a system includes an infusion device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system receives laboratory information associated with a patient, compares current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device, determines that administration of the medication by the infusion device should be prevented based on comparing the operating parameters with the operating limit parameters in view of the laboratory information and, responsive to determining that the operation should be prevented, prevents the administration of the medication by the infusion device, and generates a notification indicating that the operating limit parameters require modification.
    Type: Application
    Filed: March 27, 2023
    Publication date: July 27, 2023
    Inventors: Vikas GUPTA, Stephen J. BOLLISH, Gail BERGLUND, Timothy W. VANDERVEEN, Alan DAVISON, Donald HALBERT, Jesse J. GUERRA
  • Patent number: 11615871
    Abstract: Systems for use with a medical device for controlling an infusion device are provided. In one aspect, a system includes an infusion device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system receives laboratory information associated with a patient, compares current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device, determines that administration of the medication by the infusion device should be prevented based on comparing the operating parameters with the operating limit parameters in view of the laboratory information and, responsive to determining that the operation should be prevented, prevents the administration of the medication by the infusion device, and generates a notification indicating that the operating limit parameters require modification.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: March 28, 2023
    Assignee: CAREFUSION 303, INC.
    Inventors: Vikas Gupta, Stephen J. Bollish, Gail Berglund, Timothy W. Vanderveen, Alan Davison, Donald Halbert, Jesse J. Guerra
  • Patent number: 11525535
    Abstract: A hand disassembly rotational valve coupling for tool less manipulation by a user's hands and fingers using a coupling housing body defining an output seal aperture close to an output handle retention slot and slot lip, where the slot lip has a slot handle gap and an output seal retainer including a coupling handle ring with a first triangulated offset body retention ears and hand graspable handles separated by a ring handle gap for hand assembly and disassembly from the coupling housing body.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: December 13, 2022
    Inventors: Clay Owens, Alan Davison, Chris Clouse
  • Patent number: 11287047
    Abstract: A split body, rotary C gate, removeable stem vacuum valve using an input assembly with handle extensions that allow for hand movement of the incoming pipe to access an inner aperture body with a curved sealing face that directly seals to a C shaped gasketless gate that can be rotated into and out of the inner body aperture for easy cleaning. The gasketless gate is held in position using gate axles with an outer axle stem connected to a polygon lower body that mates into a matching polygon aperture on the gasketless gate. The middle valve assembly's gasketless housing body defines upper and lower axle washer pockets for locating the axles for proper operation and simple axle pins for securing the axles in position.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: March 29, 2022
    Inventors: Clay Owens, Alan Davison, Chris Clouse, Jerry George McGarrah
  • Publication number: 20210151146
    Abstract: Systems for use with a medical device for controlling an infusion device are provided. In one aspect, a system includes an infusion device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system receives laboratory information associated with a patient, compares current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device, determines that administration of the medication by the infusion device should be prevented based on comparing the operating parameters with the operating limit parameters in view of the laboratory information and, responsive to determining that the operation should be prevented, prevents the administration of the medication by the infusion device, and generates a notification indicating that the operating limit parameters require modification.
    Type: Application
    Filed: January 26, 2021
    Publication date: May 20, 2021
    Inventors: Vikas GUPTA, Stephen J. BOLLISH, Gail BERGLUND, Timothy W. VANDERVEEN, Alan DAVISON, Donald HALBERT, Jesse J. GUERRA
  • Patent number: 10937530
    Abstract: Systems for use with a medical device for reducing medication errors are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database includes acceptable operating parameters for providing the medication to the patient using the medical device, and a processor. The processor is configured to compare the acceptable operating parameters with the patient-specific information, and provide a modification of the operating limit parameters for providing the medication to the patient based on the comparison of the acceptable operating parameters with the patient-specific information. Methods and machine-readable media are also provided.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: March 2, 2021
    Assignee: CareFusion 303, Inc.
    Inventors: Vikas Gupta, Stephen J. Bollish, Gail Berglund, Timothy W. Vanderveen, Alan Davison, Donald Halbert, Jesse J. Guerra
  • Publication number: 20180326146
    Abstract: Systems for use with a medical device for reducing medication errors are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database includes acceptable operating parameters for providing the medication to the patient using the medical device, and a processor. The processor is configured to compare the acceptable operating parameters with the patient-specific information, and provide a modification of the operating limit parameters for providing the medication to the patient based on the comparison of the acceptable operating parameters with the patient-specific information. Methods and machine-readable media are also provided.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: Vikas GUPTA, Stephen J. BOLLISH, Gail BERGLUND, Timothy W. VANDERVEEN, Alan DAVISON, Donald HALBERT, Jesse J. GUERRA
  • Patent number: 10029047
    Abstract: Systems for use with a medical device for reducing medication errors are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database includes acceptable operating parameters for providing the medication to the patient using the medical device, and a processor. The processor is configured to compare the acceptable operating parameters with the patient-specific information, and provide a modification of the operating limit parameters for providing the medication to the patient based on the comparison of the acceptable operating parameters with the patient-specific information. Methods and machine-readable media are also provided.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: July 24, 2018
    Assignee: CAREFUSION 303, INC.
    Inventors: Vikas Gupta, Stephen J. Bollish, Gail Berglund, Timothy W. Vanderveen, Alan Davison, Donald Halbert, Jesse J. Guerra
  • Publication number: 20150250948
    Abstract: Systems for use with a medical device for reducing medication errors are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database includes acceptable operating parameters for providing the medication to the patient using the medical device, and a processor. The processor is configured to compare the acceptable operating parameters with the patient-specific information, and provide a modification of the operating limit parameters for providing the medication to the patient based on the comparison of the acceptable operating parameters with the patient-specific information. Methods and machine-readable media are also provided.
    Type: Application
    Filed: May 26, 2015
    Publication date: September 10, 2015
    Inventors: Vikas GUPTA, Stephen J. BOLLISH, Gail BERGLUND, Timothy W. VANDERVEEN, Alan DAVISON, Donald HALBERT, Jesse J. GUERRA
  • Patent number: 9069887
    Abstract: Systems for use with a medical device for reducing medication errors are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database includes acceptable operating parameters for providing the medication to the patient using the medical device, and a processor. The processor is configured to compare the acceptable operating parameters with the patient-specific information, and provide a modification of the operating limit parameters for providing the medication to the patient based on the comparison of the acceptable operating parameters with the patient-specific information. Methods and machine-readable media are also provided.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 30, 2015
    Assignee: CareFusion 303, Inc.
    Inventors: Vikas Gupta, Stephen J. Bollish, Gail Berglund, Timothy W. Vanderveen, Alan Davison, Donald Halbert, Jesse J. Guerra
  • Publication number: 20080226550
    Abstract: The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods of imaging tumors using radiolabeled metal complexes. Preferred radiolabeled complexes for imaging tumors include technetium and rhenium complexes. The high tumor uptake and significant tumor/nontumor ratios of the technetium complexes of the invention indicate that such small technetium-99m-based molecular probes can be developed as in-vivo diagnostic agents for melanoma and its metastases. In yet another embodiment, the invention relates to methods of treatment of tumors using a radiolabeled metal complex as a radiopharmaceutical agent to treat the tumor.
    Type: Application
    Filed: January 21, 2008
    Publication date: September 18, 2008
    Inventors: Ashfaq Mahmood, Matthias Friebe, Cristina Bolzati, Alun G. Jones, Alan Davison
  • Patent number: 7321027
    Abstract: The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods of imaging tumors using radiolabeled metal complexes. Preferred radiolabeled complexes for imaging tumors include technetium and rhenium complexes. The high tumor uptake and significant tumor/nontumor ratios of the technetium complexes of the invention indicate that such small technetium-99m-based molecular probes can be developed as in-vivo diagnostic agents for melanoma and its metastases. In yet another embodiment, the invention relates to methods of treatment of tumors using a radiolabeled metal complex as a radiopharmaceutical agent to treat the tumor.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: January 22, 2008
    Assignees: President and Fellows of Harvard College, Massachusetts Institute of Technology
    Inventors: Ashfaq Mahmood, Matthias Friebe, Cristina Bolzati, Alun G. Jones, Alan Davison
  • Publication number: 20060159617
    Abstract: The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the methods of imaging tissues, organs or tumors using radiolabeled metal complexes, particularly tissues, organs, or tumors which express certain receptors to which the compounds or complexes of the invention have an affinity. The present invention also relates to methods of treating cancer, particularly those cancer lines which express certain receptors to which the compounds or complexes of the invention have an affinity. In yet another embodiment, the present invention provides methods of imaging and/or inhibiting receptors or neuroreceptors using compounds or complexes of the invention which have an affinity for the receptor or neuroreceptor to be imaged and/or inhibited.
    Type: Application
    Filed: November 8, 2003
    Publication date: July 20, 2006
    Inventors: Ashfaq Mahmood, Zhen Cheng, Alun Jones, Alan Davison
  • Publication number: 20040097735
    Abstract: The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods of imaging tumors using radiolabeled metal complexes. Preferred radiolabeled complexes for imaging tumors include technetium and rhenium complexes. The high tumor uptake and significant tumor/nontumor ratios of the technetium complexes of the invention indicate that such small technetium-99m-based molecular probes can be developed as in-vivo diagnostic agents for melanoma and its metastases. In yet another embodiment, the invention relates to methods of treatment of tumors using a radiolabeled metal complex as a radiopharmaceutical agent to treat the tumor.
    Type: Application
    Filed: October 23, 2002
    Publication date: May 20, 2004
    Applicants: President and Fellows of Harvard College, Massachusetts Institute of Technology
    Inventors: Ashfaq Mahmood, Matthias Friebe, Cristina Bolzati, Alun G. Jones, Alan Davison
  • Patent number: 6171576
    Abstract: Radiopharmaceutical compounds are disclosed. A tropane compound is linked through the N atom at the 8-position to a chelating ligand capable of complexing technetium or rhenium to produce a neutral labeled complex that selectively binds to the dopamine transporter. These compounds can be prepared as separate diastereoisomers as well as a mixture of diastereoisomers. Also disclosed are radiopharmaceutical kits for preparing the labeled radiopharmaceutical compounds.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: January 9, 2001
    Assignees: Organix Inc., President & Fellows of Harvard College, Massachusetts Institute of Technology
    Inventors: Peter C. Meltzer, Bertha K. Madras, Alan Davison, Paul Blundell, Ashfaq Mahmood, Alun G. Jones
  • Patent number: 6054114
    Abstract: Novel organometallic compounds for binding amyloid are described. Methods using such compounds for determining by imaging the localization or quantification of amyloid fibrils in a mammal, for diagnosing the degree of progression of Alzheimer's disease in a mammal, for monitoring the response to a therapy in a mammal having Alzheimer's disease, for identifying an agent useful for treating Alzheimer's disease, for treating Alzheimer's disease, and for detecting the presence of the infectious form of the prion protein, are also described.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: April 25, 2000
    Assignee: Massachusetts Institute of Technology
    Inventors: Peter T. Lansbury, Jr., Hogyu Han, Cheon-Gyu Cho, Weiguo Zhen, James D. Harper, Alan Davison
  • Patent number: 5692382
    Abstract: In order to chill foodstuffs and the like type of material a modular chilling unit is provided with a jacketed trough through which a chilled non-cryogenic coolant such as glycol is circulated, and wherein the material to be cooled is moved along the cooled trough using an auger. The chilling unit is arranged so that it can be mounted on another so that the material is transferred from one to another under the influence of gravity and so that the length of chilling path can be suitably elongated. The troughs are each rotatably supported by a structure which allows rotation to a near inverted position wherein jets of cleaning fluid can be ejected into the interior of the trough.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: December 2, 1997
    Assignee: Food Processing Equipment Corp.
    Inventor: Alan Davison
  • Patent number: 5670048
    Abstract: A preparatory supercritical extraction cartridge includes a chamber for sample having a volume in the range of 20 cubic centimeters to 2,000 cubic centimeters. An inlet and an outlet are fastened to the cartridge walls by threads and sealed to said cartridge walls With spring loaded seals so that they can be removed with a torque requirement of less than 35 pound inches. Inlet and outlet tubing are fastened to the inlet and outlet by quick release connectors.
    Type: Grant
    Filed: February 14, 1996
    Date of Patent: September 23, 1997
    Assignee: Isco, Inc.
    Inventors: Dale Alan Davison, Henry LeRoy Walters
  • Patent number: 4872561
    Abstract: A coordination complex comprising a radionuclide selected from the class consisting of radioactive isotopes of Tc, Ru, Co, Pt and Re and an isonitrile ligand of the formula:(CNX)R,where X is a lower alkyl group having 1 to 4 carbon atoms, wherein R is selected from the group consisting of COOR.sup.1 and CONR.sup.2 R.sup.3 where R.sup.1 can be H, a pharmaceutically acceptable cation, or a substituted or unsubstituted alkyl group having 1 to 4 carbon atoms. R.sup.2, and R.sup.3 can be H, or a substituted or unsubstituted alkyl group having 1 to 4 carbon atoms, and R.sup.2 and R.sup.3 can be the same of different is disclosed. Kits that can be used to form these complexes are also disclosed.
    Type: Grant
    Filed: December 29, 1987
    Date of Patent: October 10, 1989
    Assignees: Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: Alun G. Jones, Alan Davison, James Kronauge, Michael J. Abrams